Document is current
Any future updates will be listed below
-
Authors
Herranz Pinto, Pedro https://orcid.org/0000-0002-9840-6628
Pérez García, Bibiana
Bonne Moreno, Victoria
Ortiz, Beky Norela
De Paz Fernández, Héctor David https://orcid.org/0000-0002-4190-5063
Lizán, Luis https://orcid.org/0000-0001-6039-2454
-
Funding
Funding for this research was provided by:
Galderma
- License Information
-
More Information
Article History
Received: 22 January 2026
Accepted: 19 February 2026
First Online: 17 March 2026
Declarations
:
: Pedro Herranz Pinto served as consultant, received honoraria for research and received speaker fees from Abbvie, Almirall, Amgen, Boehringer, Bristol Myers Squibb, Celgene, Galderma, Leopharma, Pfizer, Roche, Sanofi, Takeda, UCB pharma. Bibiana Pérez García received honoraria for research from Galderma, Sanofi, Almirall, Amgen and Incyte; served as a consultant and received speaker fees from Galderma, Sanofi, Leo, Almirall and Abbvie, and received other financial benefits from Sanofi, Abbvie and Almirall. Victoria Bonne Moreno and Beky Norela Ortiz are employees of Galderma. Héctor David De Paz Fernández, and Luis Lizán declared no conflict of interest.
: This article is based exclusively on previously published studies and does not contain any new studies with human participants or animals performed by the authors.
